SPP1 and osteosarcoma: Downregulation of osteopontin levels can prevent mesenchymal stem cells or immature osteoblasts from progressing to mature cells, allowing them to maintain the morphology and characteristics of immature primitive cells, which may ultimately lead to the development of osteosarcoma (66–69).